Literature DB >> 1933964

Effect of a media campaign to reduce delay times for acute myocardial infarction on the burden of chest pain patients in the emergency department.

J Herlitz1, M Hartford, B V Karlson, M Risenfors, M Blohm, R V Luepker, B Wennerblom, S Holmberg.   

Abstract

We evaluated the effect of a media campaign aimed at reducing delay times in suspected acute myocardial infarction (AMI) on the volume of chest pain patients seen in the emergency department. During the 1st week of the campaign, the mean number of chest pain patients increased from 10.5 per day prior to the start to 25.4. However, the number declined rapidly in subsequent months. The greatest increase was observed in patients with chest pain in whom AMI was not suspected on examination. During the campaign, 4,805 patients with chest pain appeared in the emergency department as compared with 4,407 patients during the same time period prior to its start, an increase of 9%. The number of patients with confirmed AMI increased from 595 to 629 (6%).

Entities:  

Mesh:

Year:  1991        PMID: 1933964     DOI: 10.1159/000174870

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  Can regional variation in "avoidable" mortality be explained by deaths outside hospital? A study from Sweden, 1987-90.

Authors:  R Westerling
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

2.  Impact of a public campaign on pre-hospital delay in patients reporting chest pain.

Authors:  J M Gaspoz; P F Unger; P Urban; J C Chevrolet; W Rutishauser; C Lovis; L Goldman; C Héliot; L Séchaud; S Mischler; F A Waldvogel
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

3.  An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital.

Authors:  M B Blohm; M Hartford; B W Karlson; R V Luepker; J Herlitz
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.